N of 1 Data Sharing: The Impact of Data Sharing within the Hematology–Oncology Drug Products Division of the US FDA-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

N of 1 Data Sharing: The Impact of Data Sharing within the Hematology–Oncology Drug Products Division of the US FDA

Published:2021-05 Issue:5 Volume:7 Page:395-399
ISSN:2405-8033
Container-title:Trends in Cancer
language:en
Short-container-title:Trends in Cancer

Author:

Gill Jennifer^ORCID,Prasad Vinay

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference8 articles.

1. Sharing clinical trial data: lessons from the YODA Project;Ross;STAT,2019

2. Patients with melanoma treated with an anti-PD-1 antibody beyond RECIST progression: a US Food and Drug Administration pooled analysis;Beaver;Lancet Oncol.,2018

3. Under-representation of racial minorities in prostate cancer studies submitted to the US Food and Drug Administration to support potential marketing approval, 1993-2013;Wissing;Cancer,2014

4. Survival of ethnic and racial minority patients with multiple myeloma treated with newer medications;Pulte;Blood Adv.,2018

5. Re-evaluating eligibility criteria for oncology clinical trials: analysis of investigational new drug applications in 2015;Jin;J. Clin. Oncol.,2017

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. N-of-1 Trials in Cancer Drug Development;Cancer Discovery;2023-04-18

2. FDA Oncology Center of Excellence Crowdsourcing Initiative: Outreach to the Scientific Community to Identify Research Questions for Pooled Analyses of Oncology Clinical Trial Data;Clinical Cancer Research;2023-04-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP